Literature DB >> 15710754

Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure.

Andrew J Lokuta1, Nathan A Maertz, Sivan Vadakkadath Meethal, Katherine T Potter, Timothy J Kamp, Héctor H Valdivia, Robert A Haworth.   

Abstract

BACKGROUND: Reduced sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a isoform) activity is a major determinant of reduced contractility in heart failure. Ca2+-ATPase inactivation can occur through SERCA2a nitration. We therefore investigated the role of SERCA2a nitration in heart failure. METHODS AND
RESULTS: We measured SERCA2a levels and nitrotyrosine levels in tissue from normal and failing human hearts using Western blots. We found that nitrotyrosine levels in idiopathic dilated cardiomyopathic (DCM) hearts were almost double those of control hearts in age-matched groups. Nitrotyrosine was dominantly present in a single protein with the molecular weight of SERCA2a, and immunoprecipitation confirmed that the protein recognized by the nitrotyrosine antibody was SERCA2a. There was a positive correlation between the time to half relaxation and the nitrotyrosine/SERCA2a content (P<0.01) in myocytes isolated from control and DCM hearts. In experiments with isolated SR vesicles from porcine hearts, we also showed that the Ca pump is inactivated by peroxynitrite exposure, and inactivation was prevented by protein kinase A pretreatment.
CONCLUSIONS: We conclude that SERCA2a inactivation by nitration may contribute to Ca pump failure and hence heart failure in DCM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710754     DOI: 10.1161/01.CIR.0000156461.81529.D7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  49 in total

Review 1.  β-Adrenergic receptor subtype signaling in heart: from bench to bedside.

Authors:  Anthony Yiu Ho Woo; Rui-ping Xiao
Journal:  Acta Pharmacol Sin       Date:  2012-01-30       Impact factor: 6.150

2.  Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Free Radic Biol Med       Date:  2008-04-04       Impact factor: 7.376

Review 3.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 4.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

5.  Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo.

Authors:  Sandra Levrand; Christine Vannay-Bouchiche; Benoît Pesse; Pal Pacher; François Feihl; Bernard Waeber; Lucas Liaudet
Journal:  Free Radic Biol Med       Date:  2006-06-07       Impact factor: 7.376

Review 6.  Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?

Authors:  Amanda L Denniss; Alexander M Dashwood; Peter Molenaar; Nicole A Beard
Journal:  Biophys Rev       Date:  2020-07-22

7.  Spontaneous atrial fibrillation initiated by tyramine in canine atria with increased sympathetic nerve sprouting.

Authors:  Ayaka Numata; Yasushi Miyauchi; Norihiko Ono; Michael C Fishbein; William J Mandel; Shien-Fong Lin; James N Weiss; Peng-Sheng Chen; Hrayr S Karagueuzian
Journal:  J Cardiovasc Electrophysiol       Date:  2011-10-28

Review 8.  Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart.

Authors:  Soban Umar; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2009-07-19       Impact factor: 3.396

9.  Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.

Authors:  H León; I Baczkó; G Sawicki; P E Light; R Schulz
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

10.  Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Cardiovasc Res       Date:  2007-09-19       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.